What is meant by intention to treat analysis? Survey of published randomised controlled trials
- 11 September 1999
- Vol. 319 (7211), 670-674
- https://doi.org/10.1136/bmj.319.7211.670
Abstract
Objectives: To assess the methodological quality of intention to treat analysis as reported in randomised controlled trials in four large medical journals. Design: Survey of all reports of randomised controlled trials published in 1997 in the BMJ, Lancet, JAMA, and New England Journal of Medicine. Main outcome measures: Methods of dealing with deviations from random allocation and missing data. Results: 119 (48%) of the reports mentioned intention to treat analysis. Of these, 12 excluded any patients who did not start the allocated intervention and three did not analyse all randomised subjects as allocated. Five reports explicitly stated that there were no deviations from random allocation. The remaining 99 reports seemed to analyse according to random allocation, but only 34 of these explicitly stated this. 89 (75%) trials had some missing data on the primary outcome variable. The methods used to deal with this were generally inadequate, potentially leading to a biased treatment effect. 29 (24%) trials had more than 10% of responses missing for the primary outcome, the methodsof handling the missing responses were similar in this subset. Conclusions: The intention to treat approach is often inadequately described and inadequately applied. Authors should explicitly describe the handling of deviations from randomised allocation and missing responses and discuss the potential effect of any missing response. Readers should critically assess the validity of reported intention to treat analyses. Intention to treat gives a pragmatic estimate of the benefit of a change in treatment policy rather than of potential benefit in patients who receive treatment exactly as planned Full application of intention to treat is possible only when complete outcome data are available for all randomised subjects About half of all published reports of randomised controlled trials stated that intention to treat was used, but handling of deviations from randomised allocation varied widely Many trials had some missing data on the primary outcome variable, and methods used to deal with this were generally inadequate, potentially leading to bias Intention to treat analyses are often inadequately described and inadequately appliedKeywords
This publication has 39 references indexed in Scilit:
- Effectiveness of antidepressantsThe British Journal of Psychiatry, 1999
- Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipientsThe Lancet, 1997
- Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancerThe Lancet, 1997
- Improving the quality of reporting of randomized controlled trials. The CONSORT statementJAMA, 1996
- Effect of non‐random missing data mechanisms in clinical trialsStatistics in Medicine, 1995
- Intention-to-Treat Analysis: Implications for Quantitative and Qualitative ResearchInternational Journal of Epidemiology, 1992
- Compliance as an Explanatory Variable in Clinical TrialsJournal of the American Statistical Association, 1991
- On estimating efficacy from clinical trialsStatistics in Medicine, 1991
- Adjusting for early treatment termination in comparative clinical trialsStatistics in Medicine, 1990
- Influence of Adherence to Treatment and Response of Cholesterol on Mortality in the Coronary Drug ProjectNew England Journal of Medicine, 1980